1-(2-methoxyphenyl)-4-(3-(methylphenylacetate-4-yl-oxy)-2-hydroxypropyl)-piperazine

ID: ALA4215889

PubChem CID: 145971621

Max Phase: Preclinical

Molecular Formula: C23H30N2O5

Molecular Weight: 414.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1

Standard InChI:  InChI=1S/C23H30N2O5/c1-28-22-6-4-3-5-21(22)25-13-11-24(12-14-25)16-19(26)17-30-20-9-7-18(8-10-20)15-23(27)29-2/h3-10,19,26H,11-17H2,1-2H3

Standard InChI Key:  QBMBZYSVGFDWTF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   11.9923   -2.7817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9912   -3.6013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6992   -4.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4089   -3.6008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4060   -2.7781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6974   -2.3729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6950   -1.5557    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4015   -1.1450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1104   -1.5514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8169   -1.1407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1128   -2.3686    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5258   -1.5472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5227   -2.3614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2275   -2.7678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9364   -2.3606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9359   -1.5424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2266   -1.1315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6425   -2.7693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6405   -3.5876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3470   -3.9967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0561   -3.5886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0541   -2.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3470   -2.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6990   -4.8274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9912   -5.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9910   -6.0530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2836   -4.8271    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5758   -5.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9320   -3.9949    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2251   -3.5850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 10 12  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 18  1  0
  3 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 19 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4215889

    ---

Associated Targets(non-human)

Thoracic aorta (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.50Molecular Weight (Monoisotopic): 414.2155AlogP: 1.97#Rotatable Bonds: 9
Polar Surface Area: 71.47Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.25CX LogP: 2.57CX LogD: 2.33
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: -1.02

References

1. Huang JJ, Zhang ZH, He F, Liu XW, Xu XJ, Dai LJ, Liu QM, Yuan M..  (2018)  Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on α1D/1A-adrenoreceptor subtypes.,  28  (4): [PMID:29422390] [10.1016/j.bmcl.2018.01.068]

Source